A systematic analysis of intrinsic regulators for HIV-1 R5 to X4 phenotypic switch
- 95 Downloads
Human immunodeficiency virus isolates most often use chemokine receptor CCR5 or CXCR4 as a co-receptor to enter target cells. During early stages of HIV-1 infection, CCR5-tropic viruses are the predominant species. The CXCR4-tropic viruses may emerge late in infection. Recognition of factors influencing this phenotypic switch may give some hints on the antiviral strategies like anti-HIV/AIDS drugs, gene therapy and vaccines.
To investigate the mechanism that triggers R5 to X4 phenotypic switch, we performed a systematic sensitivity analysis based on a five-dimensional model with time-varying parameters. We studied the sensitivity of each factor to the CCR5-to-CXCR4 tropism switch and acquired some interesting outcomes beyond expectation.
The death rate of free virus (dV), rate that uninfected CD4+ Tcells arise from precursors (s) and proliferate as stimulated by antigens (r), and in vivo viral burst size (N) are four robust factors which are constantly observed to have a strong correlation with the evolution of viral phenotype for most patients longitudinally.
Crucial factors, which are essential to phenotypic switch and disease progression, are almost the same for different patients at different time points, including the production of both virus and CD4+ Tcells and the decay of virion. It is also worth mentioning that although the sequence of factors sorted by the influence varies between patients, the trends of influences engendered by most factors as disease progresses are similar inter-patients.
KeywordsHIV-1 R5-to-X4 switch two-strain model population dynamics sensitivity analysis
We acknowledge the supports from the National Natural Science Foundation of China (Nos. 11402227, 11621062 and 11432012), the Fundamental Research Funds for the Central Universities of China (No. 2015QNA4034), and the Thousand Young Talents Program of China.
- 2.Koot, M., Keet, I. P. M., Vos, A. H. V., de Goede, R. E. Y., Roos, M. T. L., Coutinho, R. A., Miedema, F., Schellekens, P. T. A. and Tersmette, M. (1993) Prognostic value of HIV-1 syncytiuminducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med., 118, 681–688CrossRefPubMedGoogle Scholar
- 8.van Rij, R. P., Hazenberg, M. D., van Benthem, B. H. B., Otto, S. A., Prins, M., Miedema, F. and Schuitemaker, H. (2003) Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution. AIDS Res. Hum. Retroviruses, 19, 389–398CrossRefPubMedGoogle Scholar
- 11.Fouchier, R. A. M., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F. and Schuitemaker, H. (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol., 66, 3183–3187PubMedPubMedCentralGoogle Scholar
- 12.De Jong, J. J., De Ronde, A., Keulen, W., Tersmette, M. and Goudsmit, J. (1992) Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol., 66, 6777–6780PubMedPubMedCentralGoogle Scholar
- 14.Eckstein, D. A., Penn, M. L., Korin, Y. D., Scripture-Adams, D. D., Zack, J. A., Kreisberg, J. F., Roederer, M., Sherman, M. P., Chin, P. S. and Goldsmith, M. A. (2001) HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues. Immunity, 15, 671–682CrossRefPubMedGoogle Scholar
- 15.Trouplin, V., Salvatori, F., Cappello, F., Obry, V., Brelot, A., Heveker, N., Alizon, M., Scarlatti, G., Clavel, F. and Mammano, F. (2001) Determination of coreceptor usage of human immuno-deficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J. Virol., 75, 251–259CrossRefPubMedPubMedCentralGoogle Scholar
- 17.van’ t Wout, A. B., Blaak, H., Ran, L. J., Brouwer, M., Kuiken, C. and Schuitemaker, H. (1998) Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J. Virol., 72, 5099–5107Google Scholar
- 22.Berkowitz, R. D., Alexander, S., Bare, C., Linquist-Stepps, V., Bogan, M., Moreno, M. E., Gibson, L., Wieder, E. D., Kosek, J., Stoddart, C. A., et al. (1998) CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J. Virol., 72, 10108–10117PubMedPubMedCentralGoogle Scholar
- 23.Le, A. Q., Taylor, J., Dong, W., McCloskey, R., Woods, C., Danroth, R., Hayashi, K., Milloy, M. J., Poon, A. F. Y. and Brumme, Z. L. (2015) Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5Δ32/Δ32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction. Sci. Rep., 5, 17607CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Merrill, S. J. (1987) AIDS: Background and the dynamics of the decline of immunocompetence, pp. 59–75. In Theoretical Immunology WorkshopGoogle Scholar
- 34.Hazenberg, M. D., Stuart, J. W., Otto, S. A., Borleffs, J. C. C., Boucher, C. A. B., de Boer, R. J., Miedema, F. and Hamann, D. (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood, 95, 249–255PubMedGoogle Scholar